Tag: Dr Thangarajan Rajkumar
Evolution of immunotherapy for cancer treatment
Efforts are underway to identify better biomarkers to avoid unnecessary therapy and financial toxicity, writes Dr Thangarajan Rajkumar, Director Research (Oncology), MedGenome
BioVoice eMagazine September 2024 | Issue 5 | Volume 5
The Cover Story focuses on India's crucial role in ensuring global vaccine security with an exclusive interview of Dr Krishna Ella, Executive Chairman, Bharat Biotech & President, Indian Vaccine Manufacturers Association. Read interviews of Sriram Natarajan, CEO, Molbio Diagnostics and Dr Renuka Diwan, CEO, BioPrime Agrisolutions. Also features Expert Insights, Special Story and Startup Special.





















































